MOVING INTELLIGENT CHANGE FORWARD |
|
I’m thankful for the opportunity to engage with so many individuals who not only champion the importance of patient-centered health care, but also actively work to achieve it. I believe we are at a tipping point where those with the "might" (data, dollars, dias) are exploring the impact of doing the right thing: delivering technologies, services, and care that match the needs and health goals of patients, families, and caregivers. We have work to do in driving incentives in research, regulatory oversight, and payment to create accountability and transparency that must exist to accelerate learning. It’s heartening to see so many organizations stepping up to lead. What can you do to add to the momentum? |
|
Bolstering Our Ability To Value Health Technology: A Few Less-Considered Issues |
Proposals for a national entity to produce and assess evidence about the relative value of medical technology have found new energy in recent years. Efforts to create such an organization, however, are not new. The history of health policy in the United States includes multiple abandoned efforts to establish this type of body. |
|
|
Pursuing Health Care Value Post-COVID-19: Keep The Focus On Patients |
As the nation begins to slowly emerge from the COVID-19 crisis and considers how to live with SARS CoV-2 as a likely endemic virus, it is essential that we apply the lessons learned from the pandemic to clinical research, health care delivery, public health, and policy more broadly. |
|
|
Use of the Patient-Identified Top Health Priority in Care Decision-making for Older Adults With Multiple Chronic Conditions |
Decision-making for older adults with multimorbidity is complicated by the uncertain benefits of many disease-based interventions. Variability in health outcome goals and health care preferences further confounds decision-making for this population. |
|
|
Exploiting Real-World Data to Optimize the Use of Antibiotics |
In the treatment of infections, antibiotics have saved millions of lives. However, these drugs are also associated with well-known risks, such as rising rates of resistance in bacterial pathogens, negative impacts on the intestinal microbiome, and serious adverse events. |
|
|
Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval |
Under the accelerated approval pathway of the US Food and Drug Administration (FDA), therapeutic agents targeting serious or life-threatening diseases can receive approval on the basis of surrogate markers that are reasonably likely to predict clinical benefit conditional on the conduct of postapproval confirmatory trials. |
|
|
It’s time for individuals — not doctors or companies — to own their health data |
Health data should be like a mountain stream, flowing in a single direction with a clear purpose: improving health and medical outcomes. Instead, it’s a complex puzzle that only data scientists and physicians can meaningfully put together and use. |
|
|
Health plans, insurers need to make addressing racial inequities in health care part of their core work |
Health care companies and organizations across the country are grappling with health inequities, spurred by devastating disparities in the pandemic’s toll as well as the overdue reckoning with racial injustice that has followed the murder of George Floyd. |
|
|
Can David Feinberg fix Cerner? The new CEO of an electronic health record giant faces fresh threats |
In many ways, David Feinberg was an unconventional choice to lead Cerner, one of the nation’s largest vendors of electronic health records. As a prior CEO of health systems, he was a prominent customer of Epic, the company’s arch rival, and a longtime friend of its founder and CEO, Judy Faulkner. |
|
|
Passion + Quality = Change That Matters
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.
|
|
Momentum Health Strategies
Jennifer L Bright, MPA
(703) 628 - 0534
|
|
|
|
|
|
|
